Pulmonary function tests, or PFTs, boil down to a handful of measurements that describe how much air your lungs can hold, how quickly you can push it out, and how well oxygen crosses into your blood. The interpretation follows a pattern-recognition approach: you check whether the airflow ratio is low (obstruction), whether lung volumes are small (restriction), or both, then gauge severity and look for clues about the underlying cause. The numbers themselves are straightforward once you know what each one represents and which thresholds matter.
The Numbers That Anchor Everything
Three values from spirometry do most of the heavy lifting. FEV1 is the volume of air you blow out in the first second of a maximal exhale. FVC is the total volume you can force out from a full breath. The ratio of FEV1 to FVC tells you what fraction of your total exhaled air comes out in that critical first second. In healthy lungs, that ratio sits around 0.75 to 0.85 in younger adults, declining gradually with age as airways naturally stiffen and lose elastic recoil.
Results are reported as a percentage of a predicted value, which is calculated from your age, height, sex, and sometimes ethnicity. If your FEV1 is 80% of predicted, you are blowing out 80% of what a healthy person of the same age and size would produce. The FEV1/FVC ratio, though, is interpreted as an absolute number rather than a percent predicted in most clinical settings.
Recognizing an Obstructive Pattern
Obstruction means air has trouble getting out. The hallmark is a low FEV1/FVC ratio, traditionally below 0.70. That fixed cutoff is used by the Global Initiative for Chronic Obstructive Lung Disease (GOLD) to confirm airflow obstruction in COPD, while FEV1 percent predicted grades how severe the obstruction is.1American Thoracic Society / PubMed Central. Severity of Airflow Obstruction Based on FEV(1)/FVC Versus FEV(1) Percent Predicted in the General U.S. Population GOLD stages run from mild (FEV1 at or above 80% predicted) through very severe (below 30% predicted).
Newer research has proposed staging severity by the FEV1/FVC ratio itself, not just FEV1 percent predicted. One approach tested in a large cohort divided the ratio into bands: 0.60 to below 0.70 as stage 1, 0.50 to below 0.60 as stage 2, 0.40 to below 0.50 as stage 3, and below 0.40 as stage 4.2Europe PMC. FEV1/FVC Severity Stages for Chronic Obstructive Pulmonary Disease The reasoning is that the ratio captures the nature of obstruction more directly than FEV1 alone, which can drop for reasons unrelated to airway narrowing. In practice, most labs still report the traditional GOLD staging, but you may see these ratio-based stages referenced alongside it.
Conditions that produce an obstructive pattern include COPD, asthma, bronchiectasis, and cystic fibrosis. If your doctor suspects asthma, the next step is often a bronchodilator response test: you inhale a short-acting bronchodilator and repeat the spirometry. A meaningful response, sometimes defined as a 12% and 200 mL improvement in FEV1, suggests reversible obstruction. One study found that a 14% or greater improvement in FEV1, and a 10% or greater improvement in FVC relative to predicted normal values, could serve as a positive response regardless of baseline values.3PubMed Central. A comparative study of bronchodilator response: utilizing pre-bronchodilator versus predicted normal values
Recognizing a Restrictive Pattern
Restriction means the lungs cannot expand fully. Both FEV1 and FVC are reduced, but because the airways themselves are not narrowed, the FEV1/FVC ratio stays normal or even goes up. The formal definition requires a reduced total lung capacity (TLC) below the fifth percentile of predicted, measured through body plethysmography or gas dilution rather than spirometry alone.4European Respiratory Journal. Are we using the right parameters to grade a restrictive ventilatory defect? A low FVC on spirometry with a normal ratio raises suspicion, but without TLC confirmation the pattern is sometimes labeled “possible restriction” or a “nonspecific pattern.”
The causes split into two broad categories. Intrapulmonary restriction comes from lung tissue itself becoming stiff, as in pulmonary fibrosis, where scarring makes the lungs hard to inflate. Extrapulmonary restriction comes from something outside the lung parenchyma limiting expansion, such as severe obesity, chest wall deformities, or large pleural effusions. The flow-volume curve can help distinguish these: in fibrotic lung disease, the stiffened tissue actually holds the small airways open during exhalation, keeping expiratory flow rates relatively high despite the low volumes. In extrapulmonary causes like heart failure, that tethering effect is absent and flows tend to be lower at the same lung volumes.5Elsevier / Respir Med. Flow-volumes indices as means to discriminate between intra- and extrapulmonary restrictive disease
When Both Patterns Overlap
A mixed obstructive-restrictive pattern shows up when the FEV1/FVC ratio is below normal and TLC is also reduced. You see this in patients with, say, COPD who also have obesity or chest wall disease, or in someone with both asthma and interstitial lung disease. Identifying the mixed pattern requires full lung volume measurements, because a low FVC alone in the presence of obstruction might just reflect air trapping rather than true restriction.6ScienceDirect. Pulmonary Function Testing Grading the Severity of Obstruction in Mixed Obstructive-Restrictive Lung Disease Grading severity in mixed disease is tricky: the obstruction component artificially lowers FEV1 beyond what the restriction alone would cause, so the lab report may overstate the severity if it only looks at FEV1 percent predicted.
What the Flow-Volume Loop Tells You
The flow-volume loop is the graphical display of airflow speed plotted against lung volume during a forced exhale and inhale. In a normal loop, the expiratory curve rises sharply to a peak and then slopes smoothly downward, while the inspiratory curve forms a roughly symmetrical arc below it. Deviations from that shape offer diagnostic clues that the numbers alone can miss.
Upper airway obstruction produces distinctive loop distortions. If the obstruction is outside the chest, such as vocal cord paralysis or laryngeal swelling, the inspiratory limb flattens while the expiratory limb stays normal. During a breath in, the negative pressure in the airway tends to collapse the floppy area, limiting inspiratory flow. During a forced exhale, positive airway pressure holds the obstruction open. The reverse happens with an intrathoracic upper airway obstruction like a tracheal tumor: the expiratory limb flattens because the positive pleural pressure during exhalation compresses the trachea at the point of narrowing. A fixed obstruction, one that does not change with the breathing phase, such as a rigid tracheal stenosis or a goiter, flattens both limbs equally.7Europe PMC. Flow volume loop as a diagnostic marker
Diffusion Capacity and the DLCO
DLCO, the diffusing capacity of the lung for carbon monoxide, measures how efficiently gas crosses from the air sacs into the bloodstream. You breathe in a tiny, harmless amount of carbon monoxide, hold your breath briefly, and exhale. The lab calculates how much of that gas was absorbed. A low DLCO points to problems at the membrane level: emphysema destroying alveolar walls, interstitial lung disease thickening them, or pulmonary vascular disease reducing blood flow past them.
One underappreciated factor is hemoglobin. Carbon monoxide binds to hemoglobin, so if you are anemic, less hemoglobin is available to pick up the test gas, and the measured DLCO drops even if the lungs themselves are fine. The standard practice is to adjust the DLCO for hemoglobin concentration. Research has shown this adjustment is linear: for men, the standard hemoglobin reference is about 14.6 g/dL, and for women about 13.4 g/dL.8American Journal of Respiratory and Critical Care Medicine. Adjustment of DLCO for hemoglobin concentration If your hemoglobin is significantly below those values, the lab should correct the DLCO upward. Without that correction, anemia can masquerade as lung disease.
Pairing the DLCO with spirometry results refines the diagnosis. A low DLCO with an obstructive pattern strongly suggests emphysema, since the destruction of alveolar walls both traps air and removes gas exchange surface. A low DLCO with a restrictive pattern fits interstitial lung disease. An isolated low DLCO with otherwise normal spirometry and lung volumes raises concern for early pulmonary vascular disease or early interstitial changes not yet severe enough to show up on spirometry.
Lung Volumes and Air Trapping
Beyond FEV1 and FVC, full lung volume measurements give a richer picture. TLC tells you how big the lungs are at maximum inflation. Residual volume (RV) is the air left behind after you exhale as hard as you can. Functional residual capacity (FRC) is the air remaining at the end of a normal, relaxed breath. The ratio of RV to TLC quantifies air trapping: a high RV/TLC means a disproportionate amount of air stays stuck in the lungs.
In COPD, the RV/TLC ratio climbs as obstruction worsens. A study of COPD patients found a strong negative correlation between RV/TLC and FEV1, meaning worse airflow limitation tracked with more trapped air. Higher RV/TLC also correlated with worse symptom scores and quality of life measures.9PubMed Central. Clinical impact of long-term change in air trapping on pulmonary function and computed tomography parameters in chronic obstructive pulmonary disease Air trapping is not limited to obstructive disease, though. A study of patients with idiopathic pulmonary fibrosis found that about a third had an RV/TLC of 0.40 or above, often in association with emphysema.10Nature. Air trapping in patients with idiopathic pulmonary fibrosis: a retrospective case—control study An elevated RV on its own, even when the FEV1/FVC ratio is normal, has been linked to underlying airway disease.11PubMed Central. Isolated Elevation in Lung Residual Volume Is Associated With Airway Diseases
The Fixed Ratio Versus the Lower Limit of Normal
This is one of the longest-running debates in PFT interpretation. The 0.70 cutoff for FEV1/FVC is simple and widely used, but it is a one-size-fits-all number applied to a ratio that naturally declines with age. In younger adults, using 0.70 can miss genuine obstruction because their normal ratio is well above that. In older adults, it flags people as obstructed whose ratio has simply drifted below 0.70 as part of healthy aging.12European Respiratory Journal. The lower limit of normal versus a fixed ratio to assess airflow limitation: will the debate ever end?
The alternative is the lower limit of normal (LLN), which is calculated from reference equations and adjusts for age, height, and sex. Research has shown that older adults who test positive for obstruction by the fixed ratio but negative by the LLN do not face the same elevated mortality risk as those who are positive by both criteria.13Karger. Difference in Mortality Risk in Elderly People with Bronchial Obstruction Diagnosed Using a Fixed Cutoff or the Lower Limit of Normal of the FEV1/FVC Ratio In one study, about 4% of COPD patients were overdiagnosed when the LLN was used as the benchmark, and overdiagnosed individuals tended to be older, heavier, and have better overall lung function.14PubMed Central. Fixed Ratio Versus Lower Limit of Normal: Health Status and Risk Factors for COPD Overdiagnosis If you are over 65 and told you have mild COPD based solely on a ratio just under 0.70, it is worth asking whether the LLN was considered.
Race-Neutral Reference Equations and Why They Matter
PFT results are only as meaningful as the reference equations used to generate predicted values. Historically, separate equations existed for different racial groups, built on the assumption that lung size varies by ethnicity. The Global Lung Function Initiative recently introduced race-neutral reference equations to replace these ethnic-specific ones.15BMJ Open Respiratory Research. Impact of race-neutral GLI reference equations in Northeast Asian patients with IPF
The switch matters because it changes who gets labeled as impaired. In a large U.S. study, replacing race-specific with race-neutral equations increased the prevalence of restriction among Black individuals from about 27% to roughly 38%, while it decreased restriction among White individuals from about 23% to 18%. Severity ratings also shifted: about 23% of Black individuals were reclassified as having more severe disease, and about 19% of White individuals were reclassified as less severe.16JAMA Network Open. Global, Race-Neutral Reference Equations and Pulmonary Function Test Interpretation In a separate study of Northeast Asians, transitioning to race-neutral equations reclassified nearly half of patients as having normal physiology or less severe impairment.17Scientific Reports. Race-neutral versus race-specific GLI reference equations on spirometry interpretation in the general population
The practical takeaway is to check which reference equations your lab used. If a report was generated using the older race-specific equations, the classification of normal versus impaired could shift under the newer standards, and the direction of that shift depends on your background.
Making Sure the Test Is Valid
A beautifully interpreted PFT is worthless if the effort behind it was poor. Labs apply strict acceptability and repeatability criteria. A valid blow must start sharply, with no hesitation at the beginning. The back-extrapolated volume, which estimates how much air leaked before the timer started, must be tiny: no more than 5% of FVC or 100 mL, whichever is greater, by the 2019 ATS/ERS standards. There must be no cough in the first second, no glottic closure, no leak around the mouthpiece, and the person must blow until a clear plateau appears or for at least 15 seconds.18American Journal of Respiratory and Critical Care Medicine. Standardization of Spirometry 2019 Update. An Official American Thoracic Society and European Respiratory Society Technical Statement
Repeatability requires at least two acceptable efforts whose FEV1 and FVC values land within 150 mL of each other.19European Respiratory Journal. Standardisation of spirometry If they don’t, the technician should ask for more blows, typically up to eight attempts. Children face different challenges: younger kids commonly fail because of glottic closure or not trying hard enough, while school-age children more often fail because they stop exhaling before reaching a plateau.20PubMed Central. Acceptability and repeatability of spirometry in children using updated ATS/ERS criteria
When you receive a PFT report, look for a quality grade. Many labs assign letter grades (A through F) based on how well the session met these criteria. An A or B means the numbers are reliable. A C or D means the results should be interpreted cautiously. An F means the data probably should not be used for clinical decisions at all.
Small Airways and the FEF 25-75 Debate
The forced expiratory flow between 25% and 75% of vital capacity (FEF 25-75) is sometimes called the “small airways number.” It reflects airflow through the mid and lower portions of the expiratory curve, which are thought to be more sensitive to narrowing in the small, peripheral airways. In smokers without overt obstruction on standard criteria, a low FEF 25-75 was associated with lower FEV1 and a lower FEV1/FVC ratio even after adjusting for smoking history, suggesting it may flag early airway disease.21BMJ Publishing Group. Small airway function measured using forced expiratory flow between 25% and 75% of vital capacity and its relationship to airflow limitation in symptomatic ever-smokers
The problem is that FEF 25-75 is highly variable from one effort to the next, depends heavily on lung volume, and has no standardized threshold for abnormality. A systematic review concluded there is no consensus on the best spirometric parameter or cutoff for defining small airway obstruction, and the clinical value of measuring it remains unclear without more large-scale longitudinal research.22BioMed Central. Spirometry parameters used to define small airways obstruction in population-based studies: systematic review If your report shows a low FEF 25-75 with otherwise normal FEV1 and FEV1/FVC, treat it as a soft signal that warrants follow-up rather than a definitive diagnosis.
How Obesity Reshapes PFT Results
Excess weight, particularly around the abdomen and chest wall, compresses the lungs from the outside and reduces how much they can expand at rest. The most characteristic change is a drop in expiratory reserve volume (ERV), the extra air you can push out below a normal exhale. FRC also falls. These reductions are detectable even with modest weight gain.23PubMed Central. Physiology of obesity and effects on lung function In severe obesity, the drop in ERV can cause airways in the lower lung zones to close during normal breathing, creating uneven airflow distribution and low oxygen levels.
TLC and FEV1/FVC often stay relatively normal until obesity becomes extreme, so the spirometry pattern in a moderately obese person can look nearly normal even though their breathing mechanics are measurably impaired. Body plethysmography revealing a reduced ERV out of proportion to other volumes is the typical giveaway. Supine measurements can also help: lying down further compresses the lungs, and the resulting additional drop in FRC distinguishes obesity-related restriction from other causes.24Scientific Reports. Pulmonary and chest wall function in obese adults
Tracking Changes Over Time
A single PFT snapshot tells you where you stand. Serial measurements over months or years reveal the trajectory, which often matters more for treatment decisions. Everyone loses lung function with age, but the rate varies. In community-dwelling older adults with mild to moderate COPD, FEV1 declined by about 66 mL per year on average, compared to roughly 43 mL per year in those without COPD.25npj Primary Care Respiratory Medicine. Annual decline rate in FEV1s in community-dwelling older adults diagnosed with mild to moderate COPD A decline that consistently outpaces the expected range signals that a disease is progressing or that a treatment is not working.
For meaningful comparisons, the tests need to be done the same way each time: same lab, same type of spirometer if possible, with the same quality standards. Time of day, recent bronchodilator use, and whether you had a respiratory infection recently can all shift numbers enough to mimic real change.
Specialized Tests Beyond Standard Spirometry
When standard spirometry and lung volumes do not explain symptoms, additional tests fill in the gaps. Maximal inspiratory pressure (MIP) and maximal expiratory pressure (MEP) assess respiratory muscle strength. You push or pull against a sealed mouthpiece as hard as you can, and the gauge measures the pressure you generate. These are especially important in neuromuscular disease: in late-onset Pompe disease, for example, MIP was able to distinguish patients who would need nighttime ventilation with high accuracy, while MEP was less discriminating between those groups.26ScienceDirect. Pulmonary function tests (maximum inspiratory pressure, maximum expiratory pressure, vital capacity, forced vital capacity) predict ventilator use in late-onset Pompe disease These tests are volitional, meaning they require your full effort and cooperation, which makes them easy to administer but sensitive to motivation.27Europe PMC. Diagnostic methods to assess inspiratory and expiratory muscle strength
Bronchial challenge testing is another specialized tool, used primarily to diagnose asthma when spirometry is normal at baseline. You inhale increasing doses of methacholine, a substance that causes airway narrowing in susceptible people, and spirometry is repeated after each dose. The test measures how much methacholine it takes to drop your FEV1 by 20%. Higher sensitivity means the airways react to smaller doses, supporting a diagnosis of airway hyperresponsiveness.28Elsevier. Methacholine challenge–comparison of an ATS protocol to a new rapid single concentration technique A negative methacholine challenge essentially rules out current asthma, making it one of the most useful “rule out” tests in pulmonary medicine.